Last reviewed · How we verify
Three doses of investigational vaccine
Three doses of investigational vaccine is a Biologic drug developed by Sinovac Biotech Co., Ltd. It is currently in Phase 1 development.
At a glance
| Generic name | Three doses of investigational vaccine |
|---|---|
| Sponsor | Sinovac Biotech Co., Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) (PHASE1)
- The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) (PHASE1)
- GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose (PHASE4)
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M (PHASE2)
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) (PHASE1)
- Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali (PHASE2)
- A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age (PHASE1)
- A Post-marketing Observational Study of Oral Cholera Vaccine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Three doses of investigational vaccine CI brief — competitive landscape report
- Three doses of investigational vaccine updates RSS · CI watch RSS
- Sinovac Biotech Co., Ltd portfolio CI
Frequently asked questions about Three doses of investigational vaccine
What is Three doses of investigational vaccine?
Three doses of investigational vaccine is a Biologic drug developed by Sinovac Biotech Co., Ltd.
Who makes Three doses of investigational vaccine?
Three doses of investigational vaccine is developed by Sinovac Biotech Co., Ltd (see full Sinovac Biotech Co., Ltd pipeline at /company/sinovac-biotech-co-ltd).
What development phase is Three doses of investigational vaccine in?
Three doses of investigational vaccine is in Phase 1.